Fortis Healthcare has announced that a meeting of the Board of Directors is scheduled for November 11, 2025. During this meeting, the board will review and approve the unaudited financial results for the quarter and half-year ended September 30, 2025 (Q2). The company has also declared a trading window closure, effective until 48 hours after the results are announced, up to November 13, 2025.
Board Meeting Scheduled
A meeting of the Board of Directors of Fortis Healthcare is slated for November 11, 2025. The primary agenda is to review and approve the unaudited financial results for the second quarter of the financial year. The results pertain to the period ending September 30, 2025 (Q2), encompassing both standalone and consolidated figures.
Trading Window Closure
In line with regulatory requirements, Fortis Healthcare has announced a temporary closure of the trading window for its securities. This closure commenced earlier and will remain in effect until 48 hours after the official announcement of the financial results. Specifically, the trading window will reopen after November 13, 2025. This measure is intended to prevent any potential insider trading during the sensitive period surrounding the financial results announcement.
Source: BSE
